EverSource Wealth Advisors’s Altimmune ALT Stock Holding History

EverSource Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.9K	Sell	19,717 -15,933	-45%	-$47.6K	﹤0.01%	1658
2026 Q1	$110K	Buy	35,650 +17,967	+102%	+$76.3K	﹤0.01%	1373
2025 Q4	$63.8K	Buy	17,683 +1,650	+10%	+$7.19K	﹤0.01%	1583
2025 Q3	$60.4K	Buy	16,033 +15,913	+13,261%	+$61.4K	﹤0.01%	1570
2025 Q2	$464	Buy	+120	New	+$649	﹤0.01%	3915
2025 Q1	–	Sell	-12	Closed	-$87	–	4017
2024 Q4	$87	Buy	+12	New	+$92	﹤0.01%	3570

Other funds holding ALT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

BWM

Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SFWA

Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors's ALT Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Altimmune (ALT) stake by 45% in Q2 2026, selling an estimated $47.6K and leaving 19,717 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

EverSource Wealth Advisors first reported a position in ALT in Q4 2024 and has held it in 6 quarters since. The position peaked at $110K in Q1 2026. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

EverSource Wealth Advisors held 19,717 shares of Altimmune worth $59.9K as of Q2 2026.
EverSource Wealth Advisors sold 15,933 Altimmune shares in Q2 2026, an estimated $47.6K.
Altimmune made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1658 holding.
EverSource Wealth Advisors first reported a position in Altimmune in Q4 2024 and has held it in 6 quarters since.
EverSource Wealth Advisors's Altimmune position peaked at $110K in Q1 2026.
38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.